Pharma & Healthcare
Global Perfluorocarbon-based Ultrasound Contrast Agents Market Outlook, In‑Depth Analysis & Forecast to 2031
- Oct 21, 25
- ID: 555896
- Pages: 139
- Figures: 149
- Views: 7
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Perfluorocarbon-based Ultrasound Contrast Agents market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Bracco
GE Healthcare
Lantheus Medical Imaging
ImaRx Therapeutics
Microvascular Therapeutics
Qi-hui Biopharmaceutical
Feiruida Medical
SUNΛ Med-Engineering
Lizhuo Pharmaceutical
Fuman Group
Segment by Type
Sulfur Hexafluoride
Perfluoropropane
Perfluorobutane
Others
Segment by Application
Liver Ultrasonography
Angiographic Ultrasonography
Cardiac Ultrasonography
Others
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Perfluorocarbon-based Ultrasound Contrast Agents study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Perfluorocarbon-based Ultrasound Contrast Agents market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Bracco
GE Healthcare
Lantheus Medical Imaging
ImaRx Therapeutics
Microvascular Therapeutics
Qi-hui Biopharmaceutical
Feiruida Medical
SUNΛ Med-Engineering
Lizhuo Pharmaceutical
Fuman Group
Segment by Type
Sulfur Hexafluoride
Perfluoropropane
Perfluorobutane
Others
Segment by Application
Liver Ultrasonography
Angiographic Ultrasonography
Cardiac Ultrasonography
Others
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Perfluorocarbon-based Ultrasound Contrast Agents study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
1 Study Coverage
1.1 Introduction to Perfluorocarbon-based Ultrasound Contrast Agents: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Sulfur Hexafluoride
1.2.3 Perfluoropropane
1.2.4 Perfluorobutane
1.2.5 Others
1.3 Market Segmentation by Application
1.3.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Liver Ultrasonography
1.3.3 Angiographic Ultrasonography
1.3.4 Cardiac Ultrasonography
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Estimates and Forecasts 2020-2031
2.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Estimates and Forecasts 2020-2031
2.4 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Sulfur Hexafluoride Market Size by Manufacturers
3.5.2 Perfluoropropane Market Size by Manufacturers
3.5.3 Perfluorobutane Market Size by Manufacturers
3.5.4 Others Market Size by Manufacturers
3.6 Global Perfluorocarbon-based Ultrasound Contrast Agents Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Perfluorocarbon-based Ultrasound Contrast Agents Sales and Revenue by Type (2020-2031)
6.4 North America Perfluorocarbon-based Ultrasound Contrast Agents Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Perfluorocarbon-based Ultrasound Contrast Agents Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales and Revenue by Type (2020-2031)
7.4 Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Perfluorocarbon-based Ultrasound Contrast Agents Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Perfluorocarbon-based Ultrasound Contrast Agents Sales and Revenue by Type (2020-2031)
9.4 Central and South America Perfluorocarbon-based Ultrasound Contrast Agents Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Perfluorocarbon-based Ultrasound Contrast Agents Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Perfluorocarbon-based Ultrasound Contrast Agents Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Bracco
11.1.1 Bracco Corporation Information
11.1.2 Bracco Business Overview
11.1.3 Bracco Perfluorocarbon-based Ultrasound Contrast Agents Product Models, Descriptions and Specifications
11.1.4 Bracco Perfluorocarbon-based Ultrasound Contrast Agents Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Bracco Perfluorocarbon-based Ultrasound Contrast Agents Sales by Product in 2024
11.1.6 Bracco Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application in 2024
11.1.7 Bracco Perfluorocarbon-based Ultrasound Contrast Agents Sales by Geographic Area in 2024
11.1.8 Bracco Perfluorocarbon-based Ultrasound Contrast Agents SWOT Analysis
11.1.9 Bracco Recent Developments
11.2 GE Healthcare
11.2.1 GE Healthcare Corporation Information
11.2.2 GE Healthcare Business Overview
11.2.3 GE Healthcare Perfluorocarbon-based Ultrasound Contrast Agents Product Models, Descriptions and Specifications
11.2.4 GE Healthcare Perfluorocarbon-based Ultrasound Contrast Agents Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 GE Healthcare Perfluorocarbon-based Ultrasound Contrast Agents Sales by Product in 2024
11.2.6 GE Healthcare Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application in 2024
11.2.7 GE Healthcare Perfluorocarbon-based Ultrasound Contrast Agents Sales by Geographic Area in 2024
11.2.8 GE Healthcare Perfluorocarbon-based Ultrasound Contrast Agents SWOT Analysis
11.2.9 GE Healthcare Recent Developments
11.3 Lantheus Medical Imaging
11.3.1 Lantheus Medical Imaging Corporation Information
11.3.2 Lantheus Medical Imaging Business Overview
11.3.3 Lantheus Medical Imaging Perfluorocarbon-based Ultrasound Contrast Agents Product Models, Descriptions and Specifications
11.3.4 Lantheus Medical Imaging Perfluorocarbon-based Ultrasound Contrast Agents Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Lantheus Medical Imaging Perfluorocarbon-based Ultrasound Contrast Agents Sales by Product in 2024
11.3.6 Lantheus Medical Imaging Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application in 2024
11.3.7 Lantheus Medical Imaging Perfluorocarbon-based Ultrasound Contrast Agents Sales by Geographic Area in 2024
11.3.8 Lantheus Medical Imaging Perfluorocarbon-based Ultrasound Contrast Agents SWOT Analysis
11.3.9 Lantheus Medical Imaging Recent Developments
11.4 ImaRx Therapeutics
11.4.1 ImaRx Therapeutics Corporation Information
11.4.2 ImaRx Therapeutics Business Overview
11.4.3 ImaRx Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Product Models, Descriptions and Specifications
11.4.4 ImaRx Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 ImaRx Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Sales by Product in 2024
11.4.6 ImaRx Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application in 2024
11.4.7 ImaRx Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Sales by Geographic Area in 2024
11.4.8 ImaRx Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents SWOT Analysis
11.4.9 ImaRx Therapeutics Recent Developments
11.5 Microvascular Therapeutics
11.5.1 Microvascular Therapeutics Corporation Information
11.5.2 Microvascular Therapeutics Business Overview
11.5.3 Microvascular Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Product Models, Descriptions and Specifications
11.5.4 Microvascular Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Microvascular Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Sales by Product in 2024
11.5.6 Microvascular Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application in 2024
11.5.7 Microvascular Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Sales by Geographic Area in 2024
11.5.8 Microvascular Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents SWOT Analysis
11.5.9 Microvascular Therapeutics Recent Developments
11.6 Qi-hui Biopharmaceutical
11.6.1 Qi-hui Biopharmaceutical Corporation Information
11.6.2 Qi-hui Biopharmaceutical Business Overview
11.6.3 Qi-hui Biopharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Product Models, Descriptions and Specifications
11.6.4 Qi-hui Biopharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Qi-hui Biopharmaceutical Recent Developments
11.7 Feiruida Medical
11.7.1 Feiruida Medical Corporation Information
11.7.2 Feiruida Medical Business Overview
11.7.3 Feiruida Medical Perfluorocarbon-based Ultrasound Contrast Agents Product Models, Descriptions and Specifications
11.7.4 Feiruida Medical Perfluorocarbon-based Ultrasound Contrast Agents Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Feiruida Medical Recent Developments
11.8 SUNΛ Med-Engineering
11.8.1 SUNΛ Med-Engineering Corporation Information
11.8.2 SUNΛ Med-Engineering Business Overview
11.8.3 SUNΛ Med-Engineering Perfluorocarbon-based Ultrasound Contrast Agents Product Models, Descriptions and Specifications
11.8.4 SUNΛ Med-Engineering Perfluorocarbon-based Ultrasound Contrast Agents Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 SUNΛ Med-Engineering Recent Developments
11.9 Lizhuo Pharmaceutical
11.9.1 Lizhuo Pharmaceutical Corporation Information
11.9.2 Lizhuo Pharmaceutical Business Overview
11.9.3 Lizhuo Pharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Product Models, Descriptions and Specifications
11.9.4 Lizhuo Pharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Lizhuo Pharmaceutical Recent Developments
11.10 Fuman Group
11.10.1 Fuman Group Corporation Information
11.10.2 Fuman Group Business Overview
11.10.3 Fuman Group Perfluorocarbon-based Ultrasound Contrast Agents Product Models, Descriptions and Specifications
11.10.4 Fuman Group Perfluorocarbon-based Ultrasound Contrast Agents Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Fuman Group Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Perfluorocarbon-based Ultrasound Contrast Agents Industry Chain
12.2 Perfluorocarbon-based Ultrasound Contrast Agents Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Perfluorocarbon-based Ultrasound Contrast Agents Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Perfluorocarbon-based Ultrasound Contrast Agents Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Perfluorocarbon-based Ultrasound Contrast Agents Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Perfluorocarbon-based Ultrasound Contrast Agents Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
1.1 Introduction to Perfluorocarbon-based Ultrasound Contrast Agents: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Sulfur Hexafluoride
1.2.3 Perfluoropropane
1.2.4 Perfluorobutane
1.2.5 Others
1.3 Market Segmentation by Application
1.3.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Liver Ultrasonography
1.3.3 Angiographic Ultrasonography
1.3.4 Cardiac Ultrasonography
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Estimates and Forecasts 2020-2031
2.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Estimates and Forecasts 2020-2031
2.4 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Sulfur Hexafluoride Market Size by Manufacturers
3.5.2 Perfluoropropane Market Size by Manufacturers
3.5.3 Perfluorobutane Market Size by Manufacturers
3.5.4 Others Market Size by Manufacturers
3.6 Global Perfluorocarbon-based Ultrasound Contrast Agents Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Perfluorocarbon-based Ultrasound Contrast Agents Sales and Revenue by Type (2020-2031)
6.4 North America Perfluorocarbon-based Ultrasound Contrast Agents Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Perfluorocarbon-based Ultrasound Contrast Agents Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales and Revenue by Type (2020-2031)
7.4 Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Perfluorocarbon-based Ultrasound Contrast Agents Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Perfluorocarbon-based Ultrasound Contrast Agents Sales and Revenue by Type (2020-2031)
9.4 Central and South America Perfluorocarbon-based Ultrasound Contrast Agents Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Perfluorocarbon-based Ultrasound Contrast Agents Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Perfluorocarbon-based Ultrasound Contrast Agents Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Bracco
11.1.1 Bracco Corporation Information
11.1.2 Bracco Business Overview
11.1.3 Bracco Perfluorocarbon-based Ultrasound Contrast Agents Product Models, Descriptions and Specifications
11.1.4 Bracco Perfluorocarbon-based Ultrasound Contrast Agents Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Bracco Perfluorocarbon-based Ultrasound Contrast Agents Sales by Product in 2024
11.1.6 Bracco Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application in 2024
11.1.7 Bracco Perfluorocarbon-based Ultrasound Contrast Agents Sales by Geographic Area in 2024
11.1.8 Bracco Perfluorocarbon-based Ultrasound Contrast Agents SWOT Analysis
11.1.9 Bracco Recent Developments
11.2 GE Healthcare
11.2.1 GE Healthcare Corporation Information
11.2.2 GE Healthcare Business Overview
11.2.3 GE Healthcare Perfluorocarbon-based Ultrasound Contrast Agents Product Models, Descriptions and Specifications
11.2.4 GE Healthcare Perfluorocarbon-based Ultrasound Contrast Agents Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 GE Healthcare Perfluorocarbon-based Ultrasound Contrast Agents Sales by Product in 2024
11.2.6 GE Healthcare Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application in 2024
11.2.7 GE Healthcare Perfluorocarbon-based Ultrasound Contrast Agents Sales by Geographic Area in 2024
11.2.8 GE Healthcare Perfluorocarbon-based Ultrasound Contrast Agents SWOT Analysis
11.2.9 GE Healthcare Recent Developments
11.3 Lantheus Medical Imaging
11.3.1 Lantheus Medical Imaging Corporation Information
11.3.2 Lantheus Medical Imaging Business Overview
11.3.3 Lantheus Medical Imaging Perfluorocarbon-based Ultrasound Contrast Agents Product Models, Descriptions and Specifications
11.3.4 Lantheus Medical Imaging Perfluorocarbon-based Ultrasound Contrast Agents Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Lantheus Medical Imaging Perfluorocarbon-based Ultrasound Contrast Agents Sales by Product in 2024
11.3.6 Lantheus Medical Imaging Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application in 2024
11.3.7 Lantheus Medical Imaging Perfluorocarbon-based Ultrasound Contrast Agents Sales by Geographic Area in 2024
11.3.8 Lantheus Medical Imaging Perfluorocarbon-based Ultrasound Contrast Agents SWOT Analysis
11.3.9 Lantheus Medical Imaging Recent Developments
11.4 ImaRx Therapeutics
11.4.1 ImaRx Therapeutics Corporation Information
11.4.2 ImaRx Therapeutics Business Overview
11.4.3 ImaRx Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Product Models, Descriptions and Specifications
11.4.4 ImaRx Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 ImaRx Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Sales by Product in 2024
11.4.6 ImaRx Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application in 2024
11.4.7 ImaRx Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Sales by Geographic Area in 2024
11.4.8 ImaRx Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents SWOT Analysis
11.4.9 ImaRx Therapeutics Recent Developments
11.5 Microvascular Therapeutics
11.5.1 Microvascular Therapeutics Corporation Information
11.5.2 Microvascular Therapeutics Business Overview
11.5.3 Microvascular Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Product Models, Descriptions and Specifications
11.5.4 Microvascular Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Microvascular Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Sales by Product in 2024
11.5.6 Microvascular Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application in 2024
11.5.7 Microvascular Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Sales by Geographic Area in 2024
11.5.8 Microvascular Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents SWOT Analysis
11.5.9 Microvascular Therapeutics Recent Developments
11.6 Qi-hui Biopharmaceutical
11.6.1 Qi-hui Biopharmaceutical Corporation Information
11.6.2 Qi-hui Biopharmaceutical Business Overview
11.6.3 Qi-hui Biopharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Product Models, Descriptions and Specifications
11.6.4 Qi-hui Biopharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Qi-hui Biopharmaceutical Recent Developments
11.7 Feiruida Medical
11.7.1 Feiruida Medical Corporation Information
11.7.2 Feiruida Medical Business Overview
11.7.3 Feiruida Medical Perfluorocarbon-based Ultrasound Contrast Agents Product Models, Descriptions and Specifications
11.7.4 Feiruida Medical Perfluorocarbon-based Ultrasound Contrast Agents Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Feiruida Medical Recent Developments
11.8 SUNΛ Med-Engineering
11.8.1 SUNΛ Med-Engineering Corporation Information
11.8.2 SUNΛ Med-Engineering Business Overview
11.8.3 SUNΛ Med-Engineering Perfluorocarbon-based Ultrasound Contrast Agents Product Models, Descriptions and Specifications
11.8.4 SUNΛ Med-Engineering Perfluorocarbon-based Ultrasound Contrast Agents Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 SUNΛ Med-Engineering Recent Developments
11.9 Lizhuo Pharmaceutical
11.9.1 Lizhuo Pharmaceutical Corporation Information
11.9.2 Lizhuo Pharmaceutical Business Overview
11.9.3 Lizhuo Pharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Product Models, Descriptions and Specifications
11.9.4 Lizhuo Pharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Lizhuo Pharmaceutical Recent Developments
11.10 Fuman Group
11.10.1 Fuman Group Corporation Information
11.10.2 Fuman Group Business Overview
11.10.3 Fuman Group Perfluorocarbon-based Ultrasound Contrast Agents Product Models, Descriptions and Specifications
11.10.4 Fuman Group Perfluorocarbon-based Ultrasound Contrast Agents Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Fuman Group Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Perfluorocarbon-based Ultrasound Contrast Agents Industry Chain
12.2 Perfluorocarbon-based Ultrasound Contrast Agents Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Perfluorocarbon-based Ultrasound Contrast Agents Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Perfluorocarbon-based Ultrasound Contrast Agents Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Perfluorocarbon-based Ultrasound Contrast Agents Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Perfluorocarbon-based Ultrasound Contrast Agents Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global Perfluorocarbon-based Ultrasound Contrast Agents Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Perfluorocarbon-based Ultrasound Contrast Agents Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Units)
Table 7. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Region (2020-2025) & (Units)
Table 8. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Region (2026-2031) & (Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Manufacturers (2020-2025) & (Units)
Table 11. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Share by Manufacturers (2020-2025)
Table 12. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Perfluorocarbon-based Ultrasound Contrast Agents by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Perfluorocarbon-based Ultrasound Contrast Agents as of 2024)
Table 16. Global Perfluorocarbon-based Ultrasound Contrast Agents Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Perfluorocarbon-based Ultrasound Contrast Agents Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Perfluorocarbon-based Ultrasound Contrast Agents Manufacturing Base and Headquarters
Table 19. Global Perfluorocarbon-based Ultrasound Contrast Agents Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type (2020-2025) & (Units)
Table 23. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type (2026-2031) & (Units)
Table 24. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Perfluorocarbon-based Ultrasound Contrast Agents ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application (2020-2025) & (Units)
Table 29. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application (2026-2031) & (Units)
Table 30. Perfluorocarbon-based Ultrasound Contrast Agents High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Perfluorocarbon-based Ultrasound Contrast Agents ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Perfluorocarbon-based Ultrasound Contrast Agents Growth Accelerators and Market Barriers
Table 37. North America Perfluorocarbon-based Ultrasound Contrast Agents Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Perfluorocarbon-based Ultrasound Contrast Agents Growth Accelerators and Market Barriers
Table 40. Europe Perfluorocarbon-based Ultrasound Contrast Agents Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Growth Accelerators and Market Barriers
Table 45. Southeast Asia Perfluorocarbon-based Ultrasound Contrast Agents Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Perfluorocarbon-based Ultrasound Contrast Agents Investment Opportunities and Key Challenges
Table 47. Central and South America Perfluorocarbon-based Ultrasound Contrast Agents Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Perfluorocarbon-based Ultrasound Contrast Agents Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Perfluorocarbon-based Ultrasound Contrast Agents Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Bracco Corporation Information
Table 51. Bracco Description and Major Businesses
Table 52. Bracco Product Models, Descriptions and Specifications
Table 53. Bracco Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Bracco Sales Value Proportion by Product in 2024
Table 55. Bracco Sales Value Proportion by Application in 2024
Table 56. Bracco Sales Value Proportion by Geographic Area in 2024
Table 57. Bracco Perfluorocarbon-based Ultrasound Contrast Agents SWOT Analysis
Table 58. Bracco Recent Developments
Table 59. GE Healthcare Corporation Information
Table 60. GE Healthcare Description and Major Businesses
Table 61. GE Healthcare Product Models, Descriptions and Specifications
Table 62. GE Healthcare Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. GE Healthcare Sales Value Proportion by Product in 2024
Table 64. GE Healthcare Sales Value Proportion by Application in 2024
Table 65. GE Healthcare Sales Value Proportion by Geographic Area in 2024
Table 66. GE Healthcare Perfluorocarbon-based Ultrasound Contrast Agents SWOT Analysis
Table 67. GE Healthcare Recent Developments
Table 68. Lantheus Medical Imaging Corporation Information
Table 69. Lantheus Medical Imaging Description and Major Businesses
Table 70. Lantheus Medical Imaging Product Models, Descriptions and Specifications
Table 71. Lantheus Medical Imaging Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Lantheus Medical Imaging Sales Value Proportion by Product in 2024
Table 73. Lantheus Medical Imaging Sales Value Proportion by Application in 2024
Table 74. Lantheus Medical Imaging Sales Value Proportion by Geographic Area in 2024
Table 75. Lantheus Medical Imaging Perfluorocarbon-based Ultrasound Contrast Agents SWOT Analysis
Table 76. Lantheus Medical Imaging Recent Developments
Table 77. ImaRx Therapeutics Corporation Information
Table 78. ImaRx Therapeutics Description and Major Businesses
Table 79. ImaRx Therapeutics Product Models, Descriptions and Specifications
Table 80. ImaRx Therapeutics Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. ImaRx Therapeutics Sales Value Proportion by Product in 2024
Table 82. ImaRx Therapeutics Sales Value Proportion by Application in 2024
Table 83. ImaRx Therapeutics Sales Value Proportion by Geographic Area in 2024
Table 84. ImaRx Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents SWOT Analysis
Table 85. ImaRx Therapeutics Recent Developments
Table 86. Microvascular Therapeutics Corporation Information
Table 87. Microvascular Therapeutics Description and Major Businesses
Table 88. Microvascular Therapeutics Product Models, Descriptions and Specifications
Table 89. Microvascular Therapeutics Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Microvascular Therapeutics Sales Value Proportion by Product in 2024
Table 91. Microvascular Therapeutics Sales Value Proportion by Application in 2024
Table 92. Microvascular Therapeutics Sales Value Proportion by Geographic Area in 2024
Table 93. Microvascular Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents SWOT Analysis
Table 94. Microvascular Therapeutics Recent Developments
Table 95. Qi-hui Biopharmaceutical Corporation Information
Table 96. Qi-hui Biopharmaceutical Description and Major Businesses
Table 97. Qi-hui Biopharmaceutical Product Models, Descriptions and Specifications
Table 98. Qi-hui Biopharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Qi-hui Biopharmaceutical Recent Developments
Table 100. Feiruida Medical Corporation Information
Table 101. Feiruida Medical Description and Major Businesses
Table 102. Feiruida Medical Product Models, Descriptions and Specifications
Table 103. Feiruida Medical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Feiruida Medical Recent Developments
Table 105. SUNΛ Med-Engineering Corporation Information
Table 106. SUNΛ Med-Engineering Description and Major Businesses
Table 107. SUNΛ Med-Engineering Product Models, Descriptions and Specifications
Table 108. SUNΛ Med-Engineering Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. SUNΛ Med-Engineering Recent Developments
Table 110. Lizhuo Pharmaceutical Corporation Information
Table 111. Lizhuo Pharmaceutical Description and Major Businesses
Table 112. Lizhuo Pharmaceutical Product Models, Descriptions and Specifications
Table 113. Lizhuo Pharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Lizhuo Pharmaceutical Recent Developments
Table 115. Fuman Group Corporation Information
Table 116. Fuman Group Description and Major Businesses
Table 117. Fuman Group Product Models, Descriptions and Specifications
Table 118. Fuman Group Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Fuman Group Recent Developments
Table 120. Key Raw Materials Distribution
Table 121. Raw Materials Key Suppliers
Table 122. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 123. Milestones in Production Technology Evolution
Table 124. Distributors List
Table 125. Market Trends and Market Evolution
Table 126. Market Drivers and Opportunities
Table 127. Market Challenges, Risks, and Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Perfluorocarbon-based Ultrasound Contrast Agents Product Picture
Figure 2. Global Perfluorocarbon-based Ultrasound Contrast Agents Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Sulfur Hexafluoride Product Picture
Figure 4. Perfluoropropane Product Picture
Figure 5. Perfluorobutane Product Picture
Figure 6. Others Product Picture
Figure 7. Global Perfluorocarbon-based Ultrasound Contrast Agents Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Liver Ultrasonography
Figure 9. Angiographic Ultrasonography
Figure 10. Cardiac Ultrasonography
Figure 11. Others
Figure 12. Perfluorocarbon-based Ultrasound Contrast Agents Report Years Considered
Figure 13. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2020-2031) & (US$ Million)
Figure 15. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 16. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Region (2020-2031)
Figure 17. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales (2020-2031) & (Units)
Figure 18. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales (CAGR) by Region (2020-2031) (Units)
Figure 19. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Region (2020-2031)
Figure 20. Top 5 and Top 10 Manufacturers Perfluorocarbon-based Ultrasound Contrast Agents Sales Volume Market Share in 2024
Figure 21. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share Ranking (2024)
Figure 22. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 23. Sulfur Hexafluoride Revenue Market Share by Manufacturer in 2024
Figure 24. Perfluoropropane Revenue Market Share by Manufacturer in 2024
Figure 25. Perfluorobutane Revenue Market Share by Manufacturer in 2024
Figure 26. Others Revenue Market Share by Manufacturer in 2024
Figure 27. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Type (2020-2031)
Figure 28. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Type (2020-2031)
Figure 29. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Application (2020-2031)
Figure 30. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Application (2020-2031)
Figure 31. North America Perfluorocarbon-based Ultrasound Contrast Agents Sales YoY (2020-2031) & (Units)
Figure 32. North America Perfluorocarbon-based Ultrasound Contrast Agents Revenue YoY (2020-2031) & (US$ Million)
Figure 33. North America Top 5 Manufacturers Perfluorocarbon-based Ultrasound Contrast Agents Sales Revenue (US$ Million) in 2024
Figure 34. North America Perfluorocarbon-based Ultrasound Contrast Agents Sales Volume (Units) by Type (2020- 2031)
Figure 35. North America Perfluorocarbon-based Ultrasound Contrast Agents Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 36. North America Perfluorocarbon-based Ultrasound Contrast Agents Sales Volume (Units) by Application (2020-2031)
Figure 37. North America Perfluorocarbon-based Ultrasound Contrast Agents Sales Revenue (US$ Million) by Application (2020-2031)
Figure 38. US Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2020-2031) & (US$ Million)
Figure 39. Canada Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2020-2031) & (US$ Million)
Figure 40. Mexico Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2020-2031) & (US$ Million)
Figure 41. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales YoY (2020-2031) & (Units)
Figure 42. Europe Perfluorocarbon-based Ultrasound Contrast Agents Revenue YoY (2020-2031) & (US$ Million)
Figure 43. Europe Top 5 Manufacturers Perfluorocarbon-based Ultrasound Contrast Agents Sales Revenue (US$ Million) in 2024
Figure 44. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Volume (Units) by Type (2020-2031)
Figure 45. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Revenue (US$ Million) by Type (2020-2031)
Figure 46. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Volume (Units) by Application (2020-2031)
Figure 47. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Revenue (US$ Million) by Application (2020-2031)
Figure 48. Germany Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2020-2031) & (US$ Million)
Figure 49. France Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2020-2031) & (US$ Million)
Figure 50. U.K. Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2020-2031) & (US$ Million)
Figure 51. Italy Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2020-2031) & (US$ Million)
Figure 52. Russia Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2020-2031) & (US$ Million)
Figure 53. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales YoY (2020-2031) & (Units)
Figure 54. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Revenue YoY (2020-2031) & (US$ Million)
Figure 55. Asia-Pacific Top 8 Manufacturers Perfluorocarbon-based Ultrasound Contrast Agents Sales Revenue (US$ Million) in 2024
Figure 56. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales Volume (Units) by Type (2020- 2031)
Figure 57. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 58. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales Volume (Units) by Application (2020-2031)
Figure 59. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales Revenue (US$ Million) by Application (2020-2031)
Figure 60. Indonesia Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2020-2031) & (US$ Million)
Figure 61. Japan Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2020-2031) & (US$ Million)
Figure 62. South Korea Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2020-2031) & (US$ Million)
Figure 63. China Taiwan Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2020-2031) & (US$ Million)
Figure 64. India Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2020-2031) & (US$ Million)
Figure 65. Central and South America Perfluorocarbon-based Ultrasound Contrast Agents Sales YoY (2020-2031) & (Units)
Figure 66. Central and South America Perfluorocarbon-based Ultrasound Contrast Agents Revenue YoY (2020-2031) & (US$ Million)
Figure 67. Central and South America Top 5 Manufacturers Perfluorocarbon-based Ultrasound Contrast Agents Sales Revenue (US$ Million) in 2024
Figure 68. Central and South America Perfluorocarbon-based Ultrasound Contrast Agents Sales Volume (Units) by Type (2021-2031)
Figure 69. Central and South America Perfluorocarbon-based Ultrasound Contrast Agents Sales Revenue (US$ Million) by Type (2020-2031)
Figure 70. Central and South America Perfluorocarbon-based Ultrasound Contrast Agents Sales Volume (Units) by Application (2020-2031)
Figure 71. Central and South America Perfluorocarbon-based Ultrasound Contrast Agents Sales Revenue (US$ Million) by Application (2020-2031)
Figure 72. Brazil Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2020-2025) & (US$ Million)
Figure 73. Argentina Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2020-2025) & (US$ Million)
Figure 74. Middle East, and Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales YoY (2020-2031) & (Units)
Figure 75. Middle East and Africa Perfluorocarbon-based Ultrasound Contrast Agents Revenue YoY (2020-2031) & (US$ Million)
Figure 76. Middle East and Africa Top 5 Manufacturers Perfluorocarbon-based Ultrasound Contrast Agents Sales Revenue (US$ Million) in 2024
Figure 77. Middle East and Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales Volume (Units) by Type (2021-2031)
Figure 78. South America Perfluorocarbon-based Ultrasound Contrast Agents Sales Revenue (US$ Million) by Type (2020-2031)
Figure 79. Middle East and Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales Volume (Units) by Application (2020-2031)
Figure 80. Middle East and Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales Revenue (US$ Million) by Application (2020-2031)
Figure 81. GCC Countries Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2020-2025) & (US$ Million)
Figure 82. Turkey Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2020-2025) & (US$ Million)
Figure 83. Egypt Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2020-2025) & (US$ Million)
Figure 84. South Africa Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2020-2025) & (US$ Million)
Figure 85. Perfluorocarbon-based Ultrasound Contrast Agents Industry Chain Mapping
Figure 86. Regional Perfluorocarbon-based Ultrasound Contrast Agents Manufacturing Base Distribution (%)
Figure 87. Global Perfluorocarbon-based Ultrasound Contrast Agents Production Market Share by Region (2020-2031)
Figure 88. Perfluorocarbon-based Ultrasound Contrast Agents Production Process
Figure 89. Regional Perfluorocarbon-based Ultrasound Contrast Agents Production Cost Structure
Figure 90. Channels of Distribution (Direct Vs Distribution)
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed
Table 1. Global Perfluorocarbon-based Ultrasound Contrast Agents Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Perfluorocarbon-based Ultrasound Contrast Agents Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Units)
Table 7. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Region (2020-2025) & (Units)
Table 8. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Region (2026-2031) & (Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Manufacturers (2020-2025) & (Units)
Table 11. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Share by Manufacturers (2020-2025)
Table 12. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Perfluorocarbon-based Ultrasound Contrast Agents by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Perfluorocarbon-based Ultrasound Contrast Agents as of 2024)
Table 16. Global Perfluorocarbon-based Ultrasound Contrast Agents Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Perfluorocarbon-based Ultrasound Contrast Agents Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Perfluorocarbon-based Ultrasound Contrast Agents Manufacturing Base and Headquarters
Table 19. Global Perfluorocarbon-based Ultrasound Contrast Agents Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type (2020-2025) & (Units)
Table 23. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type (2026-2031) & (Units)
Table 24. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Perfluorocarbon-based Ultrasound Contrast Agents ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application (2020-2025) & (Units)
Table 29. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application (2026-2031) & (Units)
Table 30. Perfluorocarbon-based Ultrasound Contrast Agents High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Perfluorocarbon-based Ultrasound Contrast Agents ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Perfluorocarbon-based Ultrasound Contrast Agents Growth Accelerators and Market Barriers
Table 37. North America Perfluorocarbon-based Ultrasound Contrast Agents Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Perfluorocarbon-based Ultrasound Contrast Agents Growth Accelerators and Market Barriers
Table 40. Europe Perfluorocarbon-based Ultrasound Contrast Agents Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Growth Accelerators and Market Barriers
Table 45. Southeast Asia Perfluorocarbon-based Ultrasound Contrast Agents Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Perfluorocarbon-based Ultrasound Contrast Agents Investment Opportunities and Key Challenges
Table 47. Central and South America Perfluorocarbon-based Ultrasound Contrast Agents Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Perfluorocarbon-based Ultrasound Contrast Agents Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Perfluorocarbon-based Ultrasound Contrast Agents Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Bracco Corporation Information
Table 51. Bracco Description and Major Businesses
Table 52. Bracco Product Models, Descriptions and Specifications
Table 53. Bracco Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Bracco Sales Value Proportion by Product in 2024
Table 55. Bracco Sales Value Proportion by Application in 2024
Table 56. Bracco Sales Value Proportion by Geographic Area in 2024
Table 57. Bracco Perfluorocarbon-based Ultrasound Contrast Agents SWOT Analysis
Table 58. Bracco Recent Developments
Table 59. GE Healthcare Corporation Information
Table 60. GE Healthcare Description and Major Businesses
Table 61. GE Healthcare Product Models, Descriptions and Specifications
Table 62. GE Healthcare Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. GE Healthcare Sales Value Proportion by Product in 2024
Table 64. GE Healthcare Sales Value Proportion by Application in 2024
Table 65. GE Healthcare Sales Value Proportion by Geographic Area in 2024
Table 66. GE Healthcare Perfluorocarbon-based Ultrasound Contrast Agents SWOT Analysis
Table 67. GE Healthcare Recent Developments
Table 68. Lantheus Medical Imaging Corporation Information
Table 69. Lantheus Medical Imaging Description and Major Businesses
Table 70. Lantheus Medical Imaging Product Models, Descriptions and Specifications
Table 71. Lantheus Medical Imaging Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Lantheus Medical Imaging Sales Value Proportion by Product in 2024
Table 73. Lantheus Medical Imaging Sales Value Proportion by Application in 2024
Table 74. Lantheus Medical Imaging Sales Value Proportion by Geographic Area in 2024
Table 75. Lantheus Medical Imaging Perfluorocarbon-based Ultrasound Contrast Agents SWOT Analysis
Table 76. Lantheus Medical Imaging Recent Developments
Table 77. ImaRx Therapeutics Corporation Information
Table 78. ImaRx Therapeutics Description and Major Businesses
Table 79. ImaRx Therapeutics Product Models, Descriptions and Specifications
Table 80. ImaRx Therapeutics Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. ImaRx Therapeutics Sales Value Proportion by Product in 2024
Table 82. ImaRx Therapeutics Sales Value Proportion by Application in 2024
Table 83. ImaRx Therapeutics Sales Value Proportion by Geographic Area in 2024
Table 84. ImaRx Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents SWOT Analysis
Table 85. ImaRx Therapeutics Recent Developments
Table 86. Microvascular Therapeutics Corporation Information
Table 87. Microvascular Therapeutics Description and Major Businesses
Table 88. Microvascular Therapeutics Product Models, Descriptions and Specifications
Table 89. Microvascular Therapeutics Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Microvascular Therapeutics Sales Value Proportion by Product in 2024
Table 91. Microvascular Therapeutics Sales Value Proportion by Application in 2024
Table 92. Microvascular Therapeutics Sales Value Proportion by Geographic Area in 2024
Table 93. Microvascular Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents SWOT Analysis
Table 94. Microvascular Therapeutics Recent Developments
Table 95. Qi-hui Biopharmaceutical Corporation Information
Table 96. Qi-hui Biopharmaceutical Description and Major Businesses
Table 97. Qi-hui Biopharmaceutical Product Models, Descriptions and Specifications
Table 98. Qi-hui Biopharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Qi-hui Biopharmaceutical Recent Developments
Table 100. Feiruida Medical Corporation Information
Table 101. Feiruida Medical Description and Major Businesses
Table 102. Feiruida Medical Product Models, Descriptions and Specifications
Table 103. Feiruida Medical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Feiruida Medical Recent Developments
Table 105. SUNΛ Med-Engineering Corporation Information
Table 106. SUNΛ Med-Engineering Description and Major Businesses
Table 107. SUNΛ Med-Engineering Product Models, Descriptions and Specifications
Table 108. SUNΛ Med-Engineering Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. SUNΛ Med-Engineering Recent Developments
Table 110. Lizhuo Pharmaceutical Corporation Information
Table 111. Lizhuo Pharmaceutical Description and Major Businesses
Table 112. Lizhuo Pharmaceutical Product Models, Descriptions and Specifications
Table 113. Lizhuo Pharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Lizhuo Pharmaceutical Recent Developments
Table 115. Fuman Group Corporation Information
Table 116. Fuman Group Description and Major Businesses
Table 117. Fuman Group Product Models, Descriptions and Specifications
Table 118. Fuman Group Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Fuman Group Recent Developments
Table 120. Key Raw Materials Distribution
Table 121. Raw Materials Key Suppliers
Table 122. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 123. Milestones in Production Technology Evolution
Table 124. Distributors List
Table 125. Market Trends and Market Evolution
Table 126. Market Drivers and Opportunities
Table 127. Market Challenges, Risks, and Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Perfluorocarbon-based Ultrasound Contrast Agents Product Picture
Figure 2. Global Perfluorocarbon-based Ultrasound Contrast Agents Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Sulfur Hexafluoride Product Picture
Figure 4. Perfluoropropane Product Picture
Figure 5. Perfluorobutane Product Picture
Figure 6. Others Product Picture
Figure 7. Global Perfluorocarbon-based Ultrasound Contrast Agents Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Liver Ultrasonography
Figure 9. Angiographic Ultrasonography
Figure 10. Cardiac Ultrasonography
Figure 11. Others
Figure 12. Perfluorocarbon-based Ultrasound Contrast Agents Report Years Considered
Figure 13. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2020-2031) & (US$ Million)
Figure 15. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 16. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Region (2020-2031)
Figure 17. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales (2020-2031) & (Units)
Figure 18. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales (CAGR) by Region (2020-2031) (Units)
Figure 19. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Region (2020-2031)
Figure 20. Top 5 and Top 10 Manufacturers Perfluorocarbon-based Ultrasound Contrast Agents Sales Volume Market Share in 2024
Figure 21. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share Ranking (2024)
Figure 22. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 23. Sulfur Hexafluoride Revenue Market Share by Manufacturer in 2024
Figure 24. Perfluoropropane Revenue Market Share by Manufacturer in 2024
Figure 25. Perfluorobutane Revenue Market Share by Manufacturer in 2024
Figure 26. Others Revenue Market Share by Manufacturer in 2024
Figure 27. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Type (2020-2031)
Figure 28. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Type (2020-2031)
Figure 29. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Application (2020-2031)
Figure 30. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Application (2020-2031)
Figure 31. North America Perfluorocarbon-based Ultrasound Contrast Agents Sales YoY (2020-2031) & (Units)
Figure 32. North America Perfluorocarbon-based Ultrasound Contrast Agents Revenue YoY (2020-2031) & (US$ Million)
Figure 33. North America Top 5 Manufacturers Perfluorocarbon-based Ultrasound Contrast Agents Sales Revenue (US$ Million) in 2024
Figure 34. North America Perfluorocarbon-based Ultrasound Contrast Agents Sales Volume (Units) by Type (2020- 2031)
Figure 35. North America Perfluorocarbon-based Ultrasound Contrast Agents Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 36. North America Perfluorocarbon-based Ultrasound Contrast Agents Sales Volume (Units) by Application (2020-2031)
Figure 37. North America Perfluorocarbon-based Ultrasound Contrast Agents Sales Revenue (US$ Million) by Application (2020-2031)
Figure 38. US Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2020-2031) & (US$ Million)
Figure 39. Canada Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2020-2031) & (US$ Million)
Figure 40. Mexico Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2020-2031) & (US$ Million)
Figure 41. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales YoY (2020-2031) & (Units)
Figure 42. Europe Perfluorocarbon-based Ultrasound Contrast Agents Revenue YoY (2020-2031) & (US$ Million)
Figure 43. Europe Top 5 Manufacturers Perfluorocarbon-based Ultrasound Contrast Agents Sales Revenue (US$ Million) in 2024
Figure 44. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Volume (Units) by Type (2020-2031)
Figure 45. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Revenue (US$ Million) by Type (2020-2031)
Figure 46. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Volume (Units) by Application (2020-2031)
Figure 47. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Revenue (US$ Million) by Application (2020-2031)
Figure 48. Germany Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2020-2031) & (US$ Million)
Figure 49. France Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2020-2031) & (US$ Million)
Figure 50. U.K. Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2020-2031) & (US$ Million)
Figure 51. Italy Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2020-2031) & (US$ Million)
Figure 52. Russia Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2020-2031) & (US$ Million)
Figure 53. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales YoY (2020-2031) & (Units)
Figure 54. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Revenue YoY (2020-2031) & (US$ Million)
Figure 55. Asia-Pacific Top 8 Manufacturers Perfluorocarbon-based Ultrasound Contrast Agents Sales Revenue (US$ Million) in 2024
Figure 56. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales Volume (Units) by Type (2020- 2031)
Figure 57. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 58. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales Volume (Units) by Application (2020-2031)
Figure 59. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales Revenue (US$ Million) by Application (2020-2031)
Figure 60. Indonesia Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2020-2031) & (US$ Million)
Figure 61. Japan Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2020-2031) & (US$ Million)
Figure 62. South Korea Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2020-2031) & (US$ Million)
Figure 63. China Taiwan Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2020-2031) & (US$ Million)
Figure 64. India Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2020-2031) & (US$ Million)
Figure 65. Central and South America Perfluorocarbon-based Ultrasound Contrast Agents Sales YoY (2020-2031) & (Units)
Figure 66. Central and South America Perfluorocarbon-based Ultrasound Contrast Agents Revenue YoY (2020-2031) & (US$ Million)
Figure 67. Central and South America Top 5 Manufacturers Perfluorocarbon-based Ultrasound Contrast Agents Sales Revenue (US$ Million) in 2024
Figure 68. Central and South America Perfluorocarbon-based Ultrasound Contrast Agents Sales Volume (Units) by Type (2021-2031)
Figure 69. Central and South America Perfluorocarbon-based Ultrasound Contrast Agents Sales Revenue (US$ Million) by Type (2020-2031)
Figure 70. Central and South America Perfluorocarbon-based Ultrasound Contrast Agents Sales Volume (Units) by Application (2020-2031)
Figure 71. Central and South America Perfluorocarbon-based Ultrasound Contrast Agents Sales Revenue (US$ Million) by Application (2020-2031)
Figure 72. Brazil Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2020-2025) & (US$ Million)
Figure 73. Argentina Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2020-2025) & (US$ Million)
Figure 74. Middle East, and Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales YoY (2020-2031) & (Units)
Figure 75. Middle East and Africa Perfluorocarbon-based Ultrasound Contrast Agents Revenue YoY (2020-2031) & (US$ Million)
Figure 76. Middle East and Africa Top 5 Manufacturers Perfluorocarbon-based Ultrasound Contrast Agents Sales Revenue (US$ Million) in 2024
Figure 77. Middle East and Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales Volume (Units) by Type (2021-2031)
Figure 78. South America Perfluorocarbon-based Ultrasound Contrast Agents Sales Revenue (US$ Million) by Type (2020-2031)
Figure 79. Middle East and Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales Volume (Units) by Application (2020-2031)
Figure 80. Middle East and Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales Revenue (US$ Million) by Application (2020-2031)
Figure 81. GCC Countries Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2020-2025) & (US$ Million)
Figure 82. Turkey Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2020-2025) & (US$ Million)
Figure 83. Egypt Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2020-2025) & (US$ Million)
Figure 84. South Africa Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2020-2025) & (US$ Million)
Figure 85. Perfluorocarbon-based Ultrasound Contrast Agents Industry Chain Mapping
Figure 86. Regional Perfluorocarbon-based Ultrasound Contrast Agents Manufacturing Base Distribution (%)
Figure 87. Global Perfluorocarbon-based Ultrasound Contrast Agents Production Market Share by Region (2020-2031)
Figure 88. Perfluorocarbon-based Ultrasound Contrast Agents Production Process
Figure 89. Regional Perfluorocarbon-based Ultrasound Contrast Agents Production Cost Structure
Figure 90. Channels of Distribution (Direct Vs Distribution)
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Oral Antianginal Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Polyester BCF Yarns Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Glass Mat Reinforced Thermoplastics (GMT) for Automotive Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232